← Browse by Condition
Medical Condition

borderline resectable pancreatic adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05083247 Phase 2
Recruiting

Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Enrollment
256 pts
Location
Belgium
Sponsor
Erasme University Hospital
View Trial →